News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

F2G Ltd Completes £5 million Financing Round To Fund Pre-Clinical And Clinical Development


3/22/2006 2:44:13 PM

F2G Limited, the Manchester UK based antifungal drug discovery and development company, today announced the completion of a £5 million equity financing round with an international syndicate of existing investors and a new investor, Astellas Venture Management LLC (USA), venture capital arm of Astellas Pharma Inc.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES